NEW for 2017!!

Click here to search inspection documents FULL TEXT!

Searching is free.
No subscription.
No obligation.

Why Full-Text?

You can already search the descriptions of all of FOI’s records…and now, you can search the full text of EIRs, 483s, FDA/Industry correspondence and other inspection-related content for revealing and hard to find information:

• Preparing for your own inspections
• Designing realistic mock audits
• Researching competitors
• Learning about suppliers, clinical investigators, potential acquisitions
• And much more!

  

  

Enter your keyword(s) to search the
descriptions of unpublished FDA FOIA records:

Popular searches include: drug trade or generic names; FDA investigator names, company names, device names or 510(k) numbers & more - see Search Hints for more ideas!

Your results may include Establishment Inspection Reports; Investigator Diaries; 483s; correspondence; 510(k)s (not just summaries!); meeting records;
drug, device & biologic original & supplemental reviews & more.


The Freedom of Information Act (FOIA) requires U.S. agencies to disclose many of their records. FDA's FOIA records usually aren't on the agency website – they're files from the desk drawers of reviewers, investigators, and other officials - and FOI Services has collected over 100,000 of these documents. Contact us at infoFOI@foiservices.com for more information.


Find a Document You Need?
Add it to your cart and download it immediately.


Want Some Advice?
Contact us...our information specialists can explain document
content, help you search, and answer other questions.


Can't Find Something?
Call us at +1-301-975-9400 to place a custom request.

  

EVENTS!
Meeting:

FREE!

Document of the Week...

Biomedical Policy Issues Before Congress

The US government supports scientific and technological (S&T) advancement directly by funding and performing research and development and indirectly by creating and maintaining policies that encourage private sector efforts. In this May 2017 report, the Congressional Research Service outlines an array of S&T policy issues, including those related to biomedical R&D and physical and material sciences.
Featured until July 28 Click here to download.